B, M., MG, R., A, T., S, M., G, B., L, P., . . . S, M. (2023). The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors. Frontiers in immunology, 14, 1236824. https://doi.org/10.3389/fimmu.2023.1236824
Chicago Style (17th ed.) CitationB, Musca, Russo MG, Tushe A, Magri S, Battaggia G, Pinton L, Bonaudo C, Della Puppa A, and Mandruzzato S. "The Immune Cell Landscape of Glioblastoma Patients Highlights a Myeloid-enriched and Immune Suppressed Microenvironment Compared to Metastatic Brain Tumors." Frontiers in Immunology 14 (2023): 1236824. https://doi.org/10.3389/fimmu.2023.1236824.
MLA (9th ed.) CitationB, Musca, et al. "The Immune Cell Landscape of Glioblastoma Patients Highlights a Myeloid-enriched and Immune Suppressed Microenvironment Compared to Metastatic Brain Tumors." Frontiers in Immunology, vol. 14, 2023, p. 1236824, https://doi.org/10.3389/fimmu.2023.1236824.